Riskpilot← Back to searchSign inGet full accessAstraZeneca AB
ABActiveOrg 5560117482Forskargatan 18Manufacture of pharmaceutical preparations · NACE 2120Est. 19137543 employees
Revenue 2024
SEK 204,1B
+12% vs 2023
EBITDA margin
20.2%
+16% vs 2023
Equity ratio
68.4%
Financial strength
Net profit 2024
SEK 42,9B
-40% vs 2023
| Revenue | SEK 204,1B | +12% |
| EBITDA | SEK 41,2B | +16% |
| Net profit | SEK 42,9B | -40% |
| Total assets | SEK 446,8B | +22% |
| Equity | SEK 305,7B | +16% |
| Employees | 7543 | — |
Legal name
AstraZeneca AB
Org number
5560117482
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
31 oktober 1913
Share capital
SEK 2 054 000 000
Employees
7543 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna externa firmatecknarna
Company purpose
Bolaget har till föremål för sin verksamhet att idka tillverkning av och handel med produkter för hälsovård, sjukvård och frisk- vård, att idka finansrörelse, att äga och förvalta fast och lös egendom, däribland aktier och andelar i andra företag, samt att utföra annan med någon av nämnda rörelsegrenar sammanhängande verksamhet.
Address
Forskargatan 18
Phone
+46855326000
Email
kontakt@astrazeneca.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 52 740 000 | 57 286 000 | 87 469 000 | 107 280 000 | 114 063 000 | 165 242 000 | 181 475 000 | 204 149 000 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 21 860 000 | 21 623 000 | 16 442 000 | 26 399 000 | 25 843 000 | 31 366 000 | 19 462 000 | 23 019 000 | 35 598 000 | 41 228 000 |
| Depreciation & amort. | — | — | — | — | — | — | — | — | — | — |
| EBIT | 21 860 000 | 21 623 000 | 16 442 000 | 26 399 000 | 25 843 000 | 31 366 000 | 19 462 000 | 23 019 000 | 35 598 000 | 41 228 000 |
| Net financials | 11 702 000 | 11 581 000 | 4 854 000 | 8 337 000 | 11 593 000 | 4 519 000 | 3 559 000 | −44 264 000 | 47 157 000 | 22 454 000 |
| Profit before tax | 18 826 000 | 22 542 000 | 17 179 000 | 24 819 000 | 29 951 000 | 28 543 000 | 16 731 000 | −23 093 000 | 84 424 000 | 50 860 000 |
| Tax | −3 004 000 | −3 006 000 | −2 488 000 | −4 363 000 | −5 243 000 | −7 560 000 | −3 640 000 | −5 882 000 | −12 711 000 | −7 998 000 |
| Net profit | 15 822 000 | 19 536 000 | 14 691 000 | 20 456 000 | 24 708 000 | 20 983 000 | 13 091 000 | −28 975 000 | 71 713 000 | 42 862 000 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 252 538 000 | 292 523 000 | 291 216 000 | 291 349 000 | 310 670 000 | 317 093 000 | 316 065 000 | 270 063 000 | 365 256 000 | 446 798 000 |
| Equity | 197 824 000 | 196 057 000 | 207 761 000 | 203 777 000 | 211 685 000 | 213 168 000 | 209 309 000 | 159 334 000 | 262 803 000 | 305 665 000 |
| Long-term debt | 865 000 | 35 876 000 | 22 153 000 | 22 172 000 | 24 323 000 | 15 924 000 | 17 576 000 | 13 497 000 | 13 314 000 | 31 045 000 |
| Short-term debt | 10 309 000 | 11 303 000 | 10 626 000 | 12 609 000 | 15 454 000 | 23 722 000 | 20 259 000 | 24 951 000 | 24 273 000 | 39 899 000 |
| Total debt | 11 174 000 | 47 179 000 | 32 779 000 | 34 781 000 | 39 777 000 | 39 646 000 | 37 835 000 | 38 448 000 | 37 587 000 | 70 944 000 |
EBITDA margin
20.2%
This company
15.8%
Market median
+28% vs market
20152024
Equity ratio
68.4%
This company
38.2%
Market median
+79% vs market
20152024
Return on equity
14.0%
This company
18.4%
Market median
+24% vs market
20152024
Net profit margin
21.0%
This company
8.1%
Market median
+159% vs market
20152024
Asset turnover
0.46×
This company
1.12×
Market median
-59% vs market
20152024
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TC External Signatory | External Signatory | 2020 | — | — |
KA External Signatory | External Signatory | 2022 | — | — |
EK External Signatory | External Signatory | 2020 | — | — |
NJ External Signatory | External Signatory | 2022 | — | — |
CE External Signatory | External Signatory | 2020 | — | — |
AP External Signatory | External Signatory | 2025 | — | — |
KB Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
PJ External Signatory | External Signatory | 2022 | — | — |
EJ External Signatory | External Signatory | 2022 | — | — |
LE External Signatory | External Signatory | 2025 | — | — |
LM External Signatory | External Signatory | 2020 | — | — |
CM External Signatory | External Signatory | 2020 | — | — |
EL External Signatory | External Signatory | 2020 | — | — |
AE External Signatory | External Signatory | 2020 | — | — |
KH External Signatory | External Signatory | 2020 | — | — |
NM External Signatory | External Signatory | 2020 | — | — |
KC External Signatory | External Signatory | 2020 | — | — |
PD Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
SI Chief Auditor | Chief Auditor | 2020 | — | — |
OL External Signatory | External Signatory | 2022 | — | — |
HC External Signatory | External Signatory | 2020 | — | — |
JP External Signatory | External Signatory | 2025 | — | — |
JA External Signatory | External Signatory | 2020 | — | — |
MP External Signatory | External Signatory | 2022 | — | — |
MK External Signatory | External Signatory | 2020 | — | — |
AU External Signatory | External Signatory | 2020 | — | — |
FC External Signatory | External Signatory | 2025 | — | — |
UR External Signatory | External Signatory | 2020 | — | — |
ME External Signatory | External Signatory | 2020 | — | — |
MD External Signatory | External Signatory | 2020 | — | — |
AC External Signatory | External Signatory | 2020 | — | — |
CI External Signatory | External Signatory | 2020 | — | — |
JP External Signatory | External Signatory | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2024 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AstraZeneca AB (this company)
Astrazeneca Dunkerque Production ScsAmolyt Pharma SasGuangdong Beikang Pharmaceutical Co LtdAstrazeneca Continent BvAstrazeneca S.A.Astrazeneca DubaiACERTA PHARMA BVCat Group LtdAstrazeneca Pharm (Phils) IncFusion Pharmaceuticals IncAstrazeneca Sdn BhdAstrazeneka Pharmaceuticals L.P.ASTRAZENECA PHARM (PHILS) INCAstrazeneca Pharmaceuticals (China) Co LtdAstrazeneca Ireland LtdAstrazeneca Pharmaceutical Co LtdAcerta Pharma BvAstrazeneca India Pvt. LtdASTRAZENECA CONTINENT BVASTRAZENECA PHARMACEUTICALS (CHINA) CO LTDCAT GROUP LTDASTRAZENECA SDN BHDASTRAZENECA IRELAND LTDFUSION PHARMACEUTICALS INCASTRAZENECA INDIA PVT. LTDASTRAZENECA DUBAIASTRAZENECA PHARMACEUTICAL CO LTDASTRAZENECA S.A.GUANGDONG BEIKANG PHARMACEUTICAL CO LTDASTRAZENECA DUNKERQUE PRODUCTION SCSAMOLYT PHARMA SASBoard members of AstraZeneca AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tarlanay Cingay | External Signatory | 0 companies |
| Kerstin Anna-Lena Engvall | External Signatory | 0 companies |
| Emelie Karin Susanne Antoni | External Signatory | 0 companies |
| Niklas Johan Magnus Axelsson | External Signatory | 0 companies |
| Catharina Elisabeth Dahl | External Signatory | 0 companies |
| Anna Pia Seo-Hwa Ejeholt | External Signatory | 0 companies |
| Katarina Birgitta Ageborg | Chief Executive Officer | 0 companies |
| Petrus J M van den Oetelaar | External Signatory | 0 companies |
| Erik Jesper Bergkvist | External Signatory | 0 companies |
| Lars Erik Bogentoft | External Signatory | 0 companies |
| Lars Magnus Ysander | External Signatory | 0 companies |
| Carl Magnus Nord | External Signatory | 0 companies |
| Emma Louise Frändberg | External Signatory | 0 companies |
| Anna Elisabeth Österholm Söderman | External Signatory | 0 companies |
| Kurt Hungeberg | External Signatory | 0 companies |
| Nils Martin Sundblad | External Signatory | 0 companies |
| Karin Christina Eriksson | External Signatory | 0 companies |
| Per David Alfredsson | Chief Executive Officer | 0 companies |
| Sebastian Ionescu | Chief Auditor | 0 companies |
| Olivier Laurent Quiniou | External Signatory | 0 companies |
| Helena Christina von Platten | External Signatory | 0 companies |
| Jakob Philip Kraus | External Signatory | 0 companies |
| Jeffrey Alan Pott | External Signatory | 0 companies |
| Mats Peter Berglund | External Signatory | 0 companies |
| Monica Kristina Axén | External Signatory | 0 companies |
| Anna Ulrika Lilja | External Signatory | 0 companies |
| Frida Carlsson | External Signatory | 0 companies |
| Ursula Renata Maria Hohlneicher | External Signatory | 0 companies |
| Margareta Elisabeth Björk | External Signatory | 0 companies |
| Mats Daniel Söderström | External Signatory | 0 companies |
| Adrian Charles Noel Kemp | External Signatory | 0 companies |
| Catherine Ingrid Paule Boissier | External Signatory | 0 companies |
| Jan Peter Storm | External Signatory | 0 companies |
| Hans Sven Olov Greberg | Deputy Board Member | 0 companies |
| Benny Mikael Hansen | Board of Directors | 0 companies |
| Hans Fredrik Åsell | Board of Directors | 0 companies |
| Derek John Seaborn | Board of Directors | 0 companies |
| Malena Cecilia Olofsson Stalby | Deputy Board Member | 0 companies |
| Anders Gillis Holmén | Board of Directors | 0 companies |
| Pär Oscar Brandin | Deputy Board Member | 0 companies |
| Besiana Alite | Board of Directors | 0 companies |
| John David Samuel Adler | Board of Directors | 0 companies |
| Yvonne Louise Bertlin | Board of Directors | 0 companies |
| Vincent Bengt Muskel Berg | Deputy Board Member | 0 companies |
| James Stewart Fox | Board of Directors | 0 companies |
| Aina Nicoletta Illiano | Board of Directors | 0 companies |
| Lars-Johan Cederbrant | Board of Directors | 0 companies |
| Lars Tommy Mikael Hansson | Board of Directors | 0 companies |
| Ann Marie Maxe Ahlbom | Board of Directors | 0 companies |
| Regina Desirée Fritsche Danielson | Board of Directors | 0 companies |
| Pascal Soriot | Chairman | 0 companies |
| Anna Kristina Malmgren | Board of Directors | 0 companies |
| Karl Anders Lewenhagen | Board of Directors | 0 companies |
| Maria Gabriela Belvisi | Board of Directors | 0 companies |